A study from researchers at NewYork-Presbyterian and Weill Cornell Medicine identified economic and social conditions impacting individual and group differences in health status, known as social determinants of health, in Brooklyn and top barriers to cancer care.

When Dr. Sallie Permar was a medical student at a mission hospital in rural Zambia in the late 1990s, she saw firsthand how the AIDS virus was ravaging the population.

The Dalio Center for Health Justice at NewYork-Presbyterian, which aims to understand and address the root causes of health inequities, today announced the members of its inaugural External Advisory Board.

The American College of Cardiology (ACC) has recognized NewYork-Presbyterian Lawrence Hospital for its demonstrated expertise and commitment in treating patients with chest pain.

Brief pulses of ultrasound delivered to nerves near the kidney lowered blood pressure in people with drug-resistant hypertension, Columbia and NewYork-Presbyterian physicians have found.

Weill Cornell Medicine has received complementary grants from Genentech and the Leukemia & Lymphoma Society (LLS) to support a new program that aims to address socioeconomic and racial disparities and increase access to clinical trials for underserved patients with blood cancers living in Brooklyn and Queens.

Women who receive COVID-19 mRNA vaccines produced by Pfizer-BioNTech or Moderna while in their third trimester of pregnancy generate a strong immune response and pass protective antibodies through umbilical cord blood to their babies.

Two distinct diagnostic tests, a host/pathogen RNA sequencing platform, and spatially-resolved tissue mapping tools were created by a multidisciplinary team of Weill Cornell Medicine and NewYork-Presbyterian Hospital-led researchers and used to map SARS-CoV-2 infections at the height of the initial COVID-19 outbreak in New York City.